AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
ETHNIC-DIFFERENCES IN CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS -FREQUENCY OF THE CODON-108 158 LOW ACTIVITY ALLELE IS LOWER IN KENYANTHAN CAUCASIAN OR SOUTH-WEST ASIAN INDIVIDUALS/
Authors: MCLEOD HL SYVANEN AC GITHANGA J INDALO A ISMAIL D DEWAR K ULMANEN I SLUDDEN J
Citation: Hl. Mcleod et al., ETHNIC-DIFFERENCES IN CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS -FREQUENCY OF THE CODON-108 158 LOW ACTIVITY ALLELE IS LOWER IN KENYANTHAN CAUCASIAN OR SOUTH-WEST ASIAN INDIVIDUALS/, Pharmacogenetics, 8(3), 1998, pp. 195-199
AUTOREGULATION OF 5-FLUOROURACIL METABOLISM
Authors: MCLEOD HL SLUDDEN J HARDY SC LOCK RE HAWKSWORTH GM CASSIDY J
Citation: Hl. Mcleod et al., AUTOREGULATION OF 5-FLUOROURACIL METABOLISM, European journal of cancer, 34(10), 1998, pp. 1623-1627
PHASE-I AND PHARMACOKINETIC (PK) STUDY OF TOMUDEX (TOM) PLUS 5-FLUOROURACIL (5-FU) AND LEVOFOLINIC ACID (LFA) IN ADVANCED HEAD AND NECK ANDCOLORECTAL-CANCER
Authors: CAPONIGRO F CASARETTI R MCLEOD HL BUDILLON A CARTENI G DEVITA F AVALLONE A BIGLIETTO M TUCCI A MORSMAN J BARBARULO D CATALANO G COMELLA P COMELLA G
Citation: F. Caponigro et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF TOMUDEX (TOM) PLUS 5-FLUOROURACIL (5-FU) AND LEVOFOLINIC ACID (LFA) IN ADVANCED HEAD AND NECK ANDCOLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 610-610
PHASE-I AND PHARMACOKINETIC STUDY OF TOMUDEX (TOM) PLUS 5-FLUOROURACIL (5-FU) LEVOFOLINIC ACID (LFA) IN ADVANCED HEAD AND NECK AND COLORECTAL-CANCER
Authors: CAPONIGRO F CASARETTI R MCLEOD HL BUDILLON A DEVITA F AVALLONE A CARTENI G GRAVINA A BARBARULO D MORSMAN J FIORE F CATALANO G COMELLA P COMELLA G
Citation: F. Caponigro et al., PHASE-I AND PHARMACOKINETIC STUDY OF TOMUDEX (TOM) PLUS 5-FLUOROURACIL (5-FU) LEVOFOLINIC ACID (LFA) IN ADVANCED HEAD AND NECK AND COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 461-461
PHASE-1 PHARMACOKINETIC ANALYSIS OF AG2034 IN PATIENTS WITH SOLID TUMORS
Authors: POWRIE RH CASSIDY J ROBERTS JD SHIBATA S SPICER DV YUEN G COLLIER MA MCLEOD HL
Citation: Rh. Powrie et al., PHASE-1 PHARMACOKINETIC ANALYSIS OF AG2034 IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 604-604
A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-1 STUDY OF AG2034 GIVEN ONCE EVERY 3 WEEKS
Authors: CASSIDY J BISSETT D BAIN V MCLEOD HL SHEEDY B COLLIER M PITSULADIS M
Citation: J. Cassidy et al., A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-1 STUDY OF AG2034 GIVEN ONCE EVERY 3 WEEKS, Annals of oncology, 9, 1998, pp. 605-605
CHARACTERIZATION OF THE HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE GENE
Authors: WEI XX ELIZONDO G SAPONE A MCLEOD HL RAUNIO H FERNANDEZSALGUERO P GONZALEZ FJ
Citation: Xx. Wei et al., CHARACTERIZATION OF THE HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE GENE, Genomics (San Diego, Calif.), 51(3), 1998, pp. 391-400
EVALUATION OF THE LINEARITY OF DOCETAXEL PHARMACOKINETICS
Authors: MCLEOD HL KEARNS CM KUHN JG BRUNO R
Citation: Hl. Mcleod et al., EVALUATION OF THE LINEARITY OF DOCETAXEL PHARMACOKINETICS, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 155-159
DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETICS IN CAUCASIAN SUBJECTS
Authors: RIDGE SA SLUDDEN J BROWN O ROBERTSON L WEI XX SAPONE A FERNANDEZSALGUERO PM GONZALEZ FJ VREKEN P VANKUILENBURG ABP VANGENNIP AH MCLEOD HL
Citation: Sa. Ridge et al., DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETICS IN CAUCASIAN SUBJECTS, British journal of clinical pharmacology, 46(2), 1998, pp. 151-156
CLINICALLY RELEVANT DRUG-DRUG INTERACTIONS IN ONCOLOGY
Authors: MCLEOD HL
Citation: Hl. Mcleod, CLINICALLY RELEVANT DRUG-DRUG INTERACTIONS IN ONCOLOGY, British journal of clinical pharmacology, 45(6), 1998, pp. 539-544
LIVER DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN HUMAN, CYNOMOLGUS MONKEY, RHESUS-MONKEY, DOG, RAT AND MOUSE
Authors: SLUDDEN J HARDY SC VANDENBRANDEN MR WRIGHTON SA MCLEOD HL
Citation: J. Sludden et al., LIVER DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN HUMAN, CYNOMOLGUS MONKEY, RHESUS-MONKEY, DOG, RAT AND MOUSE, Pharmacology, 56(5), 1998, pp. 276-280
DIFFERENT THIOPURINE METHYLTRANSFERASE (TPMT) ALLELES IN CAUCASIAN AND ASIAN POPULATIONS
Authors: COLLIEDUGUID ESR PRITCHARD SC SLUDDEN J COLLIER D LI T MCLEOD HL
Citation: Esr. Collieduguid et al., DIFFERENT THIOPURINE METHYLTRANSFERASE (TPMT) ALLELES IN CAUCASIAN AND ASIAN POPULATIONS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 46-46
FREQUENCY OF LOW ACTIVITY CATECHOL-O-METHYL-TRANSFERASE (COMT) ALLELES IS LOWER IN KENYAN THAN CAUCASIAN OR SOUTHWEST ASIAN SUBJECTS
Authors: MCLEOD HL SYVANEN AC GITHANGA J INDALO A ULMANEN I SLUDDEN J
Citation: Hl. Mcleod et al., FREQUENCY OF LOW ACTIVITY CATECHOL-O-METHYL-TRANSFERASE (COMT) ALLELES IS LOWER IN KENYAN THAN CAUCASIAN OR SOUTHWEST ASIAN SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 53-53
COMPARATIVE GENOMIC HYBRIDIZATION ANALYSIS OF CHROMOSOMAL ALTERATIONSINDUCED BY THE DEVELOPMENT OF RESISTANCE TO THYMIDYLATE SYNTHASE INHIBITORS
Authors: ROONEY PH STEVENSON DAJ MARSH S JOHNSTON PG HAITES NE CASSIDY J MCLEOD HL
Citation: Ph. Rooney et al., COMPARATIVE GENOMIC HYBRIDIZATION ANALYSIS OF CHROMOSOMAL ALTERATIONSINDUCED BY THE DEVELOPMENT OF RESISTANCE TO THYMIDYLATE SYNTHASE INHIBITORS, Cancer research, 58(22), 1998, pp. 5042-5045
GENOMIC INSTABILITY AND ACQUIRED-RESISTANCE TO THYMIDYLATE SYNTHASE INHIBITORS
Authors: JAFFREY RG MARSH S PRITCHARD SC JOHNSTON PG CASSIDY J MCLEOD HL
Citation: Rg. Jaffrey et al., GENOMIC INSTABILITY AND ACQUIRED-RESISTANCE TO THYMIDYLATE SYNTHASE INHIBITORS, British Journal of Cancer, 78, 1998, pp. 72-72
CHARACTERIZATION OF DIHYDROPYRIMIDINE DEHYDROGENASE IN HUMAN COLORECTAL TUMORS
Authors: MCLEOD HL SLUDDEN J MURRAY GI KEENAN RA DAVIDSON AL PARK K KORUTH M CASSIDY J
Citation: Hl. Mcleod et al., CHARACTERIZATION OF DIHYDROPYRIMIDINE DEHYDROGENASE IN HUMAN COLORECTAL TUMORS, British Journal of Cancer, 77(3), 1998, pp. 461-465
DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETICS IN PATIENTS WITH COLORECTAL-CANCER
Authors: RIDGE SA SLUDDEN J WEI X SAPONE A BROWN O HARDY S CANNEY P FERNANDEZSALGUERO P GONZALEZ FJ CASSIDY J MCLEOD HL
Citation: Sa. Ridge et al., DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETICS IN PATIENTS WITH COLORECTAL-CANCER, British Journal of Cancer, 77(3), 1998, pp. 497-500
THIOPURINE METHYLTRANSFERASE GENOTYPE PREDICTS THERAPY-LIMITING SEVERE TOXICITY FROM AZATHIOPRINE
Authors: BLACK AJ MCLEOD HL CAPELL HA POWRIE RH MATOWE LK PRITCHARD SC COLLIEDUGUID ESR REID DM
Citation: Aj. Black et al., THIOPURINE METHYLTRANSFERASE GENOTYPE PREDICTS THERAPY-LIMITING SEVERE TOXICITY FROM AZATHIOPRINE, Annals of internal medicine, 129(9), 1998, pp. 716-718
AMPLIFICATION OF FLUORESCENT IN-SITU HYBRIDIZATION SIGNALS IN FORMALIN-FIXED PARAFFIN WAX EMBEDDED SECTIONS OF COLON-TUMOR USING BIOTINYLATED TYRAMIDE
Authors: MCKAY JA MURRAY GI KEITH WN MCLEOD HL
Citation: Ja. Mckay et al., AMPLIFICATION OF FLUORESCENT IN-SITU HYBRIDIZATION SIGNALS IN FORMALIN-FIXED PARAFFIN WAX EMBEDDED SECTIONS OF COLON-TUMOR USING BIOTINYLATED TYRAMIDE, Journal of clinical pathology-Molecular pathology, 50(6), 1997, pp. 322-325
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF 5-FLUOROURACIL IN HUMAN ERYTHROCYTES, PLASMA AND WHOLE-BLOOD
Authors: WATTANATORN W MCLEOD HL CASSIDY J KENDLE KE
Citation: W. Wattanatorn et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF 5-FLUOROURACIL IN HUMAN ERYTHROCYTES, PLASMA AND WHOLE-BLOOD, Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 233-237
COMPARISON OF 5-FLUOROURACIL PHARMACOKINETICS IN WHOLE-BLOOD, PLASMA,AND RED-BLOOD-CELLS IN PATIENTS WITH COLORECTAL-CANCER
Authors: WATTANATORN W MCLEOD HL MACKLON F REID M KENDLE KE CASSIDY J
Citation: W. Wattanatorn et al., COMPARISON OF 5-FLUOROURACIL PHARMACOKINETICS IN WHOLE-BLOOD, PLASMA,AND RED-BLOOD-CELLS IN PATIENTS WITH COLORECTAL-CANCER, Pharmacotherapy, 17(5), 1997, pp. 881-886
THERAPEUTIC DRUG-MONITORING OPPORTUNITIES IN CANCER-THERAPY
Authors: MCLEOD HL
Citation: Hl. Mcleod, THERAPEUTIC DRUG-MONITORING OPPORTUNITIES IN CANCER-THERAPY, Pharmacology & therapeutics, 74(1), 1997, pp. 39-54
MUTATIONS AT CODON-974 OF THE DPYD GENE ARE A RARE EVENT
Authors: RIDGE SA BROWN O MCMURROUGH J FERNANDEZSALGUERO P EVANS WE GONZALEZ FJ MCLEOD HL
Citation: Sa. Ridge et al., MUTATIONS AT CODON-974 OF THE DPYD GENE ARE A RARE EVENT, British Journal of Cancer, 75(2), 1997, pp. 178-179
PYRIMIDINES AND CNS REGULATION - REPLY
Authors: MCLEOD HL FERNANDEZSALGUERO P GONZALEZ FJ
Citation: Hl. Mcleod et al., PYRIMIDINES AND CNS REGULATION - REPLY, Trends in pharmacological sciences, 17(3), 1996, pp. 107-107
PHASE-I PHARMACOKINETICS AND LIMITED SAMPLING STRATEGIES FOR THE BIOREDUCTIVE ALKYLATING DRUG E09
Authors: MCLEOD HL GRAHAM MA AAMDAL S SETANOIANS A GROOT Y LUND B
Citation: Hl. Mcleod et al., PHASE-I PHARMACOKINETICS AND LIMITED SAMPLING STRATEGIES FOR THE BIOREDUCTIVE ALKYLATING DRUG E09, European journal of cancer, 32A(9), 1996, pp. 1518-1522
Risultati: 1-25 | 26-44